Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Expert Review of Hematology|July 30, 2019
Novel therapies in low- and high-risk myelodysplastic syndromeUlrich Germing, Thomas Schroeder, Jennifer Kaivers, et al.European Journal of Haematology|May 9, 2019
Spontaneous remission in a patient with very late relapse of acute myeloid leukemia 17 years after allogeneic blood stem cell transplantationChristina Rautenberg, Jennifer Kaivers, Ulrich Germing, et al.Expert Review of Hematology|July 20, 2019
Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromesGuido Kobbe, Thomas Schroeder, Christina Rautenberg, et al.International Journal of Environmental Research and Public Health|July 24, 2021
Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?Annika Kasprzak, Jennifer Kaivers, Kathrin Nachtkamp, et al.Expert Review of Anticancer Therapy|July 24, 2020
Improving the accuracy of prognostication in chronic myelomonocytic leukemiaJennifer Kaivers, Esther Schuler, Barbara Hildebrandt, et al.Blood Cancer Journal|August 11, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patientsTobias Silzle, Sabine Blum, Esther Schuler, et al.Cancer|July 27, 2017
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosisJudith Neukirchen, Michael Lauseker, Barbara Hildebrandt, et al.European Journal of Haematology|May 14, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDSChristina Rautenberg, Michael Lauseker, Jennifer Kaivers, et al.Annals of Hematology|July 29, 2021
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patientsJudith Strapatsas, Elena Calina Barbulescu, Michael Lauseker, et al.Scientific Reports|July 4, 2023
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experiencePaul Jäger, Christina Rautenberg, Jennifer Kaivers, et al.Pageof 2